Skip to main content

Conlis Global

Partnerships

At Conlis Global, our strategy and business development team seeks global and local collaborations with industry leaders and academic institutions. We focus on co-development, in- licensing, and out-licensing arrangements, intending to establish strong partnerships with hospitals, healthcare systems, loT innovators, biopharmaceutical companies, biotechnology firms, medical device researchers and manufacturers. Our goal is to maximize the market potential of our products through strategic partnerships. We look for partners with a strong commercialization team, a solid background in the medical device, biopharmaceutical, or loT industries, and a commitment to our vision. We aim to create mutually beneficial relationships where partners can leverage our innovative culture while we utilize their expertise and business networks to expand our market reach. Join us in advancing healthcare innovation and achieving shared success.

Conlis Global Inc. is excited to announce a strategic partnership with Need Code to revolutionize healthcare technology.
This collaboration merges Conlis Global’s expertise in medical devices, regulatory pathways, and clinical trials with Need Code’s innovative solutions.
Together, we will:

    • Drive Technological Innovation
    • Navigate Regulatory Pathways
    • Accelerate Product Development
    • Expand Global Market Presence

This partnership maximizes our strengths, enhances our capabilities, and ensures the efficient delivery of high-quality healthcare innovations worldwide.

Conlis Global Partners with Q Booost Inc. to providing innovative and effective consultancy solutions for  your quality needs.
Conlis Global Inc. is excited to announce a strategic partnership with  Q Boost Inc. to  provide expert advice, cutting-edge software, comprehensive training, and material support to enable any lab—whether private, industrial, or academic—to achieve the highest standards of quality management. This collaboration merges Conlis Global’s expertise in medical devices, regulatory pathways, and clinical trials with Q Boosts expertise in ISO 9001, 17025, 15189 17025, and CLIA regulations.
Together, we will:
    • Provide effective solutions to client 
    • Minimize the transition time from research and development to market launch.
    •  Expand our reach to border client base 
Conlis Global Partners with Q Booost Inc. to providing innovative and effective consultancy solutions for  your quality needs.
Conlis Global Inc. is excited to announce a strategic partnership with  Q Boost Inc. to  provide expert advice, cutting-edge software, comprehensive training, and material support to enable any lab—whether private, industrial, or academic—to achieve the highest standards of quality management. This collaboration merges Conlis Global’s expertise in medical devices, regulatory pathways, and clinical trials with Q Boosts expertise in ISO 9001, 17025, 15189 17025, and CLIA regulations.
Together, we will:
    • Provide effective solutions to client 
    • Minimize the transition time from research and development to market launch.
    •  Expand our reach to border client base 

Pipeline Product

Conlis Globals clinical development program focuses on further developing NanoCement’s properties, broadening clinical application areas and utilizing NanoCement’s unique drug- releasing properties through the development of combination products that promote bone healing and avoid infections at the site of grafting.|
Several different combinations with NanoCement have been investigated to add osteoinductive properties, meaning the ability to actively stimulate bone healing. Among other things, the Company has conducted research in the form of preclinical candidates that have combined NanoCement with bone morphogenic proteins (BMP) and Zoledronic acid. BMP

Sign up for our consultation